COMMERCE: Papworth Hospital Foundation Trust has named construction group Skanska as its preferred bidder to develop a £165m hospital building under the private finance initiative.
Under the scheme, the existing Papworth Hospital is set to move to the Cambridge Biomedical Campus. The trust claims a planned Heart and Lung Institute, a joint venture with the University of Cambridge, is dependent upon the relocation of the hospital.
Papworth’s chief executive Stephen Bridge said: “This is an important milestone in the ten-year project to move to our new site on the Cambridge Biomedical Campus”.
“In early October we heard that the Department of Health had cleared the business case to be forwarded to the Treasury for approval and today’s announcement will move us closer to realising our vision to provide the highest quality facilities for our patients”.
“The clinical, research and economic case for the new Papworth Hospital is beyond doubt and we look forward to relocating to the Cambridge Biomedical Campus which is fast becoming one of the most vibrant biomedical communities in the world.”
Patrick Maxwell, executive director of Cambridge University Health Partners, said was “delighted that the project to relocate Papworth Hospital to the Cambridge Biomedical Campus is moving forwards”.
He added: “As one of the leading academic health science centres in the country, bringing the specialist cardiothoracic services provided by Papworth on to the main site is of key importance across all three aspects of our tripartite mission – patient care, education and research.”
Information provided to HSJ